RAILY AESMED (02135): Lin Hai appointed as an independent non-executive director of the company.
Ruili Medical Beauty (02135) announced that Dr. Lin Hai has been appointed as an independent non-executive director of the Company, effective from March 27, 2026.
RAILY AESMED (02135) announces that Dr. Lin Hai has been appointed as an independent non-executive director of the company, effective from March 27, 2026.
Mr. Cao Dequan has resigned as an independent non-executive director, effective from March 27, 2026. After his resignation, Mr. Cao will no longer hold any position in the company, effective immediately.
Related Articles

PLATEAU TL (08402) announced its annual performance with a net loss of 3.6579 million Singapore dollars for shareholders, an increase of 237.45% from the previous year.

GLORY FLAME (08059) released its annual performance report, reporting a net loss of HKD 15.409 million for shareholders, a 24.22% increase compared to the previous year.

GUDOU HLDGS (08308) released its annual performance, with a net loss attributable to shareholders of 61.932 million yuan, an increase of 21.89% year-on-year.
PLATEAU TL (08402) announced its annual performance with a net loss of 3.6579 million Singapore dollars for shareholders, an increase of 237.45% from the previous year.

GLORY FLAME (08059) released its annual performance report, reporting a net loss of HKD 15.409 million for shareholders, a 24.22% increase compared to the previous year.

GUDOU HLDGS (08308) released its annual performance, with a net loss attributable to shareholders of 61.932 million yuan, an increase of 21.89% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


